8P Organic cation transporter 6 directly confers resistance to anticancer platinum drugs
نویسندگان
چکیده
منابع مشابه
Organic cation transporter 6 directly confers resistance to anticancer platinum drugs.
Organic cation transporters (OCTs) of the solute carrier family 22 have a critical role in the cellular uptake of anticancer platinum drugs. Recently, we found that a decreased OCT6 expression is associated with a reduced intracellular uptake of cisplatin (CDDP), and concomitant resistance to CDDP. In the present study, we examined whether OCTs directly confer resistance to another platinum dru...
متن کاملEncapsulation of platinum anticancer drugs by apoferritin.
Apoferritin derived from the native protein ferritin was employed to encapsulate anticancer drugs cisplatin and carboplatin.
متن کاملChiral discrimination in platinum anticancer drugs.
In this article we review the biological activity of analogs of the antitumor drug cisplatin that contain chiral amine ligands. Interaction with DNA and formation of cross-links with adjacent purine bases are considered to be the crucial steps in the antitumor activity of this class of complexes. Because double-helical DNA has a chiral structure, interaction with enantiomeric complexes of plati...
متن کاملUnderstanding and improving platinum anticancer drugs--phenanthriplatin.
Approximately half of all patients who receive anticancer chemotherapy are treated with a platinum drug. Despite the widespread use of these drugs, the only cure that can be claimed is that of testicular cancer following cisplatin treatment. This article reviews some of our recent work on phenanthriplatin, a cisplatin derivative in which a chloride ion is replaced by phenanthridine, and on one ...
متن کاملA copper connection to the uptake of platinum anticancer drugs.
C isplatin [cis-diamminedichloroplatinum (II)] is a highly active anticancer agent. This agent is curative against most testicular cancers and is highly active against a wide range of other tumor types, notably ovarian, bladder carcinoma, and non-small-cell lung cancer (1). Treatment failure is frequently caused by the development of resistance to cisplatin. Although the insensitive tumors gene...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Oncology
سال: 2015
ISSN: 0923-7534
DOI: 10.1093/annonc/mdv517.08